Itkonen, Matti K <br/><br/>
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  09 2018 
 - 495-504 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1002/cpt.947  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--administration & dosage<br/>Adult<br/>Clopidogrel--administration & dosage<br/>Computer Simulation<br/>Cross-Over Studies<br/>Cyclopropanes<br/>Cytochrome P-450 CYP2C8--genetics<br/>Cytochrome P-450 CYP2C8 Inhibitors--administration & dosage<br/>Drug Interactions<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Inactivation, Metabolic<br/>Leukotriene Antagonists--administration & dosage<br/>Male<br/>Models, Biological<br/>Oxidation-Reduction<br/>Pharmacogenetics<br/>Pharmacogenomic Variants<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prasugrel Hydrochloride--administration & dosage<br/>Quinolines--administration & dosage<br/>Risk Assessment<br/>Substrate Specificity<br/>Sulfides<br/>Young Adult